tirzepatide surmount trials Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m Tirzepatide Tops Semaglutide for Weight

A high-quality compounded option may not satisfy someone expecting FDA clinical trial data

Those with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should avoid these medications

Risk factors include central obesity, elevated triglycerides, hypertension, and impaired glucose metabolism

While mild to moderate diarrhea is a common side effect , more intense or long-lasting symptoms can lead to dehydration or signal that the dose needs adjusting

At Vedas Medical Spa & Wellness Center, we offer doctor-supervised Semaglutide treatments to help you safely and effectively shed excess weight

[cited 2023 May]